| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |